Ecolab Inc. vs VALE S.A. — Stock Comparison
Q·Score Breakdown
6.6
Neutral
Overall
6.5
Neutral
Quality
Health
Growth
Valuation
Sentiment
ECL
High-quality business with 22% return on equity and 13% profit margins.
⚠ balance sheet warrants attention.
VALE
Earnings growing 22% year-over-year.
Analyst Consensus
BUY
Target $317.48 (+22.3%)
21 analysts
HOLD
Target $17.18 (+6.2%)
25 analysts
Fundamentals
ECL
VALE
35.1×
Trailing P/E
24.5×
27.1×
Forward P/E
8.0×
12.8%
Profit Margin
7.3%
44.4%
Gross Margin
35.1%
22.4%
ROE
6.8%
10.0%
Revenue Growth
2.7%
7.8%
Earnings Growth
22.0%
1.02
Beta
0.89
—
Price / Book
—
$73.3B
Market Cap
$70.6B
$249 – $309
52-Week Range
$9 – $18
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →